Muskuloskeletal Diseases
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Cortical Changes After Upper Limb Immobilization Measured by Electroencephalography
The Effect of Telerehabilitation on Pain, Physical and Biopsychosocial Factors in Parent Carers
Approaches to Chiropractic Care in Aging Patients
Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis